Colchicine
FDA Approved
Contents
Description
Colchicine is an anti-inflammatory agent that inhibits microtubule polymerization by binding to tubulin. It is used to treat inflammatory conditions including Behçet's disease and related autoinflammatory syndromes. The drug has been used for decades and has established efficacy in reducing inflammatory episodes.
Indications & Therapeutic Use
Behçet's disease, familial Mediterranean fever, gout, pericarditis
Global Availability (9 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Buy / Source Colchicine — GNH India
139 matching products available through GNH India. Select a product to view details and request a quote on the GNH India website.
Colcamedin
EU
Colcamexx
EU
Colchanova
EU
Colchianova
EU
Colchican
EU
Colchicin
EU
Colchicin Agepha
EU
Colchicin Aliud
EU
Products and ordering are fulfilled by GNH India. You will be redirected to www.gnhindia.com.
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Colchicine
| Generic Name | Colchicine |
| Brands | 1 brand available |
| Active Ingredient | Colchicine |
| Drug Class | Behçet's disease |
| Manufacturer | Takeda Pharmaceuticals |
| Dosage Forms | Oral tablet, 0.6mg |
| Medical Code | M04AC01 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 7 days |
| Reg. Status | FDA Approved |
| Clinical Trial | NCT00848406 |
| Countries | 9 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations10 Validated Nodes